logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Emerging Therapeutic Targets In Ovarian Cancer 1st Edition Susana Banerjee

  • SKU: BELL-2128778
Emerging Therapeutic Targets In Ovarian Cancer 1st Edition Susana Banerjee
$ 31.00 $ 45.00 (-31%)

5.0

100 reviews

Emerging Therapeutic Targets In Ovarian Cancer 1st Edition Susana Banerjee instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 2.95 MB
Pages: 291
Author: Susana Banerjee, Michael A. Bookman (auth.), Stan Kaye, Robert Brown, Hani Gabra, Martin Gore (eds.)
ISBN: 9781441972156, 9781441972163, 1441972153, 1441972161
Language: English
Year: 2011
Edition: 1

Product desciption

Emerging Therapeutic Targets In Ovarian Cancer 1st Edition Susana Banerjee by Susana Banerjee, Michael A. Bookman (auth.), Stan Kaye, Robert Brown, Hani Gabra, Martin Gore (eds.) 9781441972156, 9781441972163, 1441972153, 1441972161 instant download after payment.

Despite rapid advances in understanding the biology of ovarian cancer, progress in treatment has been slow. But the prospects for improvement have never been better. A wide range of novel therapeutic targets now present themselves for clinical evaluation and initial results are certainly encouraging. In this text, all these areas are covered by experts in the field. Each chapter provides up-to-date coverage of clinical information, prefaced by a description of the rational basis for the selection of each target area and consideration of biomarkers that can be used to aid clinical evaluation. The four editors work together within the Ovarian Cancer Action collaborative research programme in London and they bring a wealth of laboratory and clinical expertise to this topic. The text should provide an invaluable source of reference for clinical and laboratory-based researchers working to meet the challenges of ovarian cancer.

Related Products